Mdm2 Plays a Positive Role As an Effector of P53-dependent Responses.
From: Department of Oncological Sciences, Mount Sinai School of Medicine, New York, New York, USA.
Cell cycle (Georgetown, Tex.)
- Publish Date: Sep 2007
- ISSN: 1551-4005
- Volume: 6
- Issue: 17
- Pages: 2143-7
- Medium: Internet
- Language: English
- Citation (JAMA): Giono Luciana E, Manfredi James J, et al. Mdm2 Plays a Positive Role As an Effector of P53-dependent Responses.. Cell Cycle Sep 2007;6:2143-7
Abstract
The p53 tumor suppressor is negatively regulated in cells by the Mdm2 protein. Mdm2 has therefore been the focus of intensive research aiming at using it as a target for cancer therapy with the ultimate goal of restoring p53 activity. Several studies have attempted to ablate Mdm2 expression or disrupt its interaction with p53 in cancer cells. While the p53-Mdm2 duo has concentrated a lot of attention, multiple new and diverse functions and targets of Mdm2 have been uncovered. Downregulation of Mdm2 using an siRNA approach has recently provided evidence for a new role of Mdm2 in the p53 response, by modulating the inhibition of the cyclin-dependent kinase 2 (cdk2) by p21. Here, this and other recent findings are discussed that support a new role for Mdm2 in the regulation of p53 response.
Mesh Headings (Keywords): Animals, Apoptosis, Cyclin-Dependent Kinase Inhibitor p21, Humans, Mice, Proto-Oncogene Proteins c-mdm2, Tumor Suppressor Protein p53
Check for Full Text / PubMed Unique Identifier (PMID): 17786043
This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.
Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.
The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.